Cancer Control

  • SWOG S1202​: A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Women with Early Stage Breast Cancer.

For more information, contact Cheryl Patz, RN, OCN, CCRC, at 360-788-8238.​​​​